The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

Doctors at Chesapeake Regional Healthcare are able to minimize the pain lung cancer patients undergo with a one-and-done ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

Lung cancer innovations are not only extending lives but also enhancing the quality of life for patients, offering renewed ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended by NICE for treating adults with ...

Explore the hidden challenges faced by lung cancer patients in South Africa, where the definition of 'treatable' ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Lung cancer is the third most common cancer and the leading cause of cancer-related deaths in the U.S., and according to the ...